Utilization of glucagon‐like peptide‐1 receptor agonists and changes in clinical characteristics in patients with type 2 diabetes by chronic kidney disease stage in Japan: A descriptive observational study using a nationwide electronic medical records database

AIM: To describe the utilization of glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) and changes in clinical characteristics before and after GLP‐1 RA initiation in patients with type 2 diabetes (T2D) by chronic kidney disease (CKD) stage. MATERIALS AND METHODS: In this retrospective descriptiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirose, Naoki, Tsujimoto, Naoto, Katayose, Taeko, Chin, Rina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300085/
https://www.ncbi.nlm.nih.gov/pubmed/34779098
http://dx.doi.org/10.1111/dom.14600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300085/
https://www.ncbi.nlm.nih.gov/pubmed/34779098
http://dx.doi.org/10.1111/dom.14600

Ejemplares similares